ALFA Filings
Every announcement, straight from the exchange
Every Medplus Health Services adverse business impact announcement on NSE and BSE, newest first, each with its own page.
Time
50 announcements
Optival Health, a MedPlus subsidiary, had drug licences suspended at five Karnataka stores for 1–7 days. Expected impact is about Rs 8.66 lakhs.
Medplus Health Services' subsidiary Optival Health faced temporary drug license suspensions for two stores by Mysore regulators. The estimated operational impact is ₹0.02 Crore.
The FDA suspended the drug license of a Medplus subsidiary's store in Prabhadevi, Maharashtra for 15 days. The financial impact is estimated at Rs 14.25 lakhs.
Medplus Health's subsidiary Optival Health faces drug license suspensions for 5-8 days across four stores in multiple states. The expected financial impact is ₹0.17 Crore.
Optival Health Solutions, a subsidiary, received a one-day drug license suspension from the Drugs Control Administration for a violation of the Drugs and Cosmetics Act.
Optival Health Solutions, a subsidiary of Medplus Health Services, received a 4-day drug license suspension for an Odisha store, impacting financials by ₹0.02 Crore.
Medplus Health Services subsidiary Optival Health faces a seven-day drug license suspension at a Karnataka store. The financial impact of this regulatory action is ₹0.12 Crore.
Medplus Health Services' subsidiary, Optival Health Solutions, faced a three-day drug license suspension at a store by the Drugs Control Administration, impacting operations by ₹0.01 Crore.
Medplus Health Services reported a 7-day drug license suspension for a subsidiary store, impacting its operations with an estimated financial loss of ₹0.02 Crore.
Medplus Health Services' subsidiary, Optival Health Solutions, faced drug license suspensions for two stores from regulatory authorities, causing a total financial impact of Rs 0.0961 Crore.
Medplus Health Services' subsidiary, Optival Health Solutions, faced a five-day drug license suspension at its Kapikad store due to regulatory violations. The impact is Rs 0.03 Crore.
Medplus Health's subsidiary faces temporary drug license suspensions at two store locations in Bangalore and Pune, resulting in an estimated financial impact of Rs 0.15 Crore.
MedPlus's subsidiary faces a 7-day drug license suspension at a Maharashtra store, with an estimated financial impact of Rs 0.0175 Crore.
Medplus Health Services reported 7-day drug license suspensions for four stores across three states. The estimated financial impact of these operational disruptions is ₹0.09 Crore.
Medplus Health Services' subsidiary, Optival Health Solutions, faces temporary drug license suspensions for two stores. The estimated financial impact is Rs 0.03 Crore.
Medplus Health Services reported a 25-day drug license suspension for its Latur store, with an estimated financial impact of Rs 0.11 Crore.
MedPlus's subsidiary, Optival Health Solutions, received a two-day drug license suspension for a store in Karnataka. The potential revenue impact is Rs 0.0071 Crore.
Medplus Health Services' subsidiary, Optival Health Solutions, received a two-day drug license suspension for a Karnataka store. The financial impact is estimated at ₹0.0029 Crore.
MedPlus Health Services' subsidiary, Optival Health, received two-day drug license suspensions for three stores. The total estimated potential revenue loss is ₹0.024 Crore.
MedPlus subsidiary Optival Health Solutions faces a 2-day drug license suspension at a Karnataka store, with a potential revenue loss of ₹0.0053 Crore.
MedPlus subsidiary Optival Health Solutions faced one to two-day drug license suspensions across three Karnataka stores. The estimated total revenue impact is approximately Rs. 1.59 lakhs.
Medplus subsidiary received a 5-day drug license suspension in Maharashtra. Potential revenue loss of Rs. 0.75 lacs is quantified for investors.
Medplus subsidiary received a 3-day drug license suspension in Bangalore. Potential revenue loss of Rs 5.13 lacs is quantified for investors.
Medplus subsidiary faces a two-day drug license suspension for one store in Davanagere. The estimated financial impact is 0.008 Crore due to regulatory non-compliance.
Medplus subsidiary Optival Health Solutions faced one-day drug license suspensions at two Karnataka stores. The regulatory action follows violations of the Drugs and Cosmetics Act.
MedPlus subsidiary received two drug license suspension orders for a Karnataka store. This halts operations at the specific location.
MedPlus subsidiary Optival Health Solutions faced one-to-three-day license suspensions at three stores in Karnataka and Andhra Pradesh. Estimated financial impact is Rs 0.0158 Crore.
MedPlus reports drug license suspensions for three stores. The incident causes a minimal potential revenue loss of ₹0.02 Crore.
MedPlus subsidiary Optival Health's Karnataka store faced a one-day drug license suspension. This resulted in a potential revenue loss of ₹0.0046 Crore.
Medplus subsidiary stores in Andhra Pradesh faced drug license suspensions. This results in a total potential revenue loss of ₹0.03 Crore.